Skip to main content

SB 866 — Pennsylvania

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances and for secure storage of xylazine; and adding provisions relating to medetomidine.

Passed one chamber 2025-2026 session Senate

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

  • SB 866 is a bill in the Pennsylvania Senate, 2025-2026 session, introduced July 24, 2025.
  • Sponsored by Michele Brooks, with 3 cosponsors.
  • Current status: passed one chamber.
  • Most recent action (June 10, 2026): Referred to Judiciary.
  • 3 recorded votes; the most recent, on June 9, 2026, passed 47-2.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: Michele Brooks

Cosponsors (3): Doug Mastriano, Christine Tartaglione, Lisa Boscola

History

  1. Introduced, completed
  2. Passed Senate, completed
  3. Passed House, in progress
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. Senate Referred to Agriculture & Rural Affairs
  2. Senate Reported as committed

    Committee vote (Agriculture & Rural Affairs): Reported as Committed: 11 yes 0 no Passed, 100% yes

  3. Senate First consideration
  4. Senate Second consideration
  5. Senate Re-referred to Appropriations
  6. Senate Re-reported as committed

    Committee vote (Appropriations): Re-Reported as Committed: 22 yes 0 no Passed, 100% yes

  7. Senate Third consideration and final passage Milestone

    FINAL PASSAGE: 47 yes 2 no, 1 other Passed, 96% yes

  8. House Referred to Judiciary Latest

Source: Open States. Last checked November 13, 2026. How we keep this accurate ›